These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38277541)

  • 1. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
    Zhang H; Wang J; Yang M
    Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
    Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
    Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma.
    Pu L; Sun Y; Pu C; Zhang X; Wang D; Liu X; Guo P; Wang B; Xue L; Sun P
    Sci Rep; 2024 Feb; 14(1):4354. PubMed ID: 38388539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC.
    Jia X; Wang Y; Yang Y; Fu Y; Liu Y
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y; Jiang J
    Cancer Biomark; 2023; 37(1):13-26. PubMed ID: 37005878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.
    Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H
    Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma.
    Guo Z; Xie Y; Zhang L; Liu S; Jiang W
    Aging (Albany NY); 2024 Jan; 16(1):267-284. PubMed ID: 38180745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma.
    Zhu Y; Jin X; Liu J
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38639274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel disulfidptosis-related lncRNAs signature in patients with HPV-negative oral squamous cell carcinoma.
    Yang F; Niu X; Zhou M; Li W
    Sci Rep; 2024 Jun; 14(1):14436. PubMed ID: 38910181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfidptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Cancer.
    Shi S; Tang X; Liu H
    Reprod Sci; 2024 Mar; 31(3):811-822. PubMed ID: 37880552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma.
    Zhong Z; Xu M; Tan J
    Pathol Oncol Res; 2022; 28():1610670. PubMed ID: 36277962
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma.
    Huang F; Zhang C; Yang W; Zhou Y; Yang Y; Yang X; Guo W; Wang B
    BMC Genomics; 2024 Feb; 25(1):155. PubMed ID: 38326754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.